Korea Republic Of to India: Potassium Import Trade Route

The Korea Republic Of to India Potassium corridor is one of India's established pharmaceutical import routes from Korea Republic Of, with 2 shipments documented worth a combined $520.3K USD. The route is dominated by CKD BIO CORPORATION, which alone accounts for roughly 100% of all import value, reflecting the consolidated nature of Korea Republic Of's potassium export sector.

Across 1 active Korea Republic Of suppliers, the average shipment value stands at $260.1K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 70% of all shipments, consistent with potassium's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 18 days port-to-port. The route has recorded an annual growth rate of 23.9%, placing it at rank #12 among India's top potassium import origins globally.

On the Indian buyer side, key Indian importers include MEDICEF PHARMA, CIPLA LIMITED. MEDICEF PHARMA is the single largest Indian importer with 1 shipments valued at $387.7K USD.

India's potassium imports from Korea Republic Of are driven primarily by a handful of large-scale Korea Republic Of manufacturers. CKD BIO CORPORATION with 2 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — Indian buyers benefit from Korea Republic Of supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — CKD BIO CORPORATION — together account for 100% of total trade value on this route. The average shipment value of $260.1K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as potassium clavulanate syloid mix 1 1 clavulanate potassium with silicon dioxide 1 1 potassium clavulanate syloid mix 1 1 clavulanate potass, suggesting that Indian buyers tend to consolidate orders across related product lines from the same Korea Republic Of supplier.

On the buying side, MEDICEF PHARMA is the largest importer with 1 shipments worth $387.7K USD — representing 75% of all potassium imports from Korea Republic Of on this route.